TECNOTREE
26.2.2024 11:51:29 CET | Business Wire | Press release
Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies announced being awarded a new multimillion-dollar deal with Umniah, a leading provider of a range of telecom solutions in the MENA region with up to 3 million subscribers. With this project, Tecnotree aims to provide AI-embedded BSS customer engagement for the operator. The deal, implementing a full BSS stack along with the Tecnotree Sensa Intelligence platform operationalizes AI across business workflows and is the second win for Tecnotree in terms of AIML-driven customer experience use case.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240226721394/en/
Tecnotree Secures Multimillion-Dollar Deal with Umniah, Pioneering Sensa AIML Embedded BSS Transformation (Photo: Business Wire)
Under this project, Umniah seeks to upgrade its current CRM system with a new CX implementation targeting improvements in NPS, reduction of churn, and an increase in ARPU. As part of the agreement, Tecnotree will deploy Sensa AI-embedded BSS applications streamlining the AI development lifecycle and driving faster time to value across products.
The applications will include a dynamic bundle of product catalogues, digital self-care and customer management, catalogue-driven order management, demand generation through omnichannel campaigns and configurable integration with leading social networks, lead and funnel management, enterprise workforce management with business process orchestration, business intelligence, and analytics capabilities, enterprise and consumer service request management, partner management, E-Shop (marketplace) & B2B self-care portal. The solution will provide the operator with a unified solution with embedded intelligence for transformation across all applications, that enables B2B2X cross-sell and up-sell capabilities.
Faisal Qamhiyah, CEO of Umniah, stated, “Launching the advanced Customer Experience (CX) platform marks a pivotal step in our transformation to revolutionize customer interactions and fulfill their digital age expectations. It demonstrates our dedication to comprehending our customers, engaging with them, and keeping them informed about the digital world's evolving landscape. With customer expectations for seamless, personalized experiences at an all-time high, this platform aims to surpass these demands by providing an in-depth perspective of customer interactions.”
Qamhiyah added, “Umniah envisions a future where its corporate clients excel in understanding and meeting their customers' dynamic needs, driving them towards sustainable growth and success in the digital age.”
Commenting on the new deal, Padma Ravichander, CEO of Tecnotree Corporation, said, “We are very excited to embark on this new chapter with Umniah, as we help them redefine unparalleled digital experiences with the help of our Digital BSS and Sensa AIML fabric, for their business transformation. Our digital BSS stack embedded with Tecnotree Sensa AIML capabilities will enable the customer to improve business agility and respond faster to market dynamics while humanizing experiences and empowering customer journey lifecycle with Sensa hyper-personalisation.”
The transformation will also enable them to optimize operational costs, while significantly improving revenue monetization capability with our AI/ML-based insights and recommendations. The collaboration marks a significant stride for Tecnotree in the field of artificial intelligence, reinforcing our commitment to enhance digital services that create business differentiation and help our customers deliver second-to-none customer experiences”
About Tecnotree
Tecnotree is a 5G-ready digital Business Support System (BSS) player, with AI/ML capabilities and multi-cloud extensibility. Tecnotree leads the way on the TM Forum Open API Conformance with 59 certified Open APIs including 9 real-world open APIs, a testament to the company's commitment to excellence, and continuously striving to deliver differentiated experiences and services to both CSPs and DSPs. Our agile and open-source digital BSS Stack comprises the full range (order-to-cash) of business processes and subscription management for telecom and other digital services industries creating opportunities beyond connectivity. Tecnotree also provides Fintech and B2B2X multi-experience digital marketplace to its subscriber base through the Tecnotree Moments platform to empower digitally connected communities across gaming, health, education, OTT, and other vertical ecosystems. Tecnotree is listed on the Helsinki Nasdaq (TEM1V).
About Umniah
Since its launch in 2005, Umniah, a subsidiary of Beyon Group, has been recognized as one the fastest growing and reliable telecommunications providers in the region’s most competitive markets, offering a wide variety of transformative high-quality mobile, Internet, and enterprise solutions. The award-winning company champions innovation, digital transformation, and technological advancement, delivering to its 3 million subscribers reliability and connectivity through an inclusive range of products and solutions that meet distinctive individual and corporate needs. The company also has a comprehensive and effective sustainability strategy that outlines its environmental, social, and corporate governance practices as well as its commitment to making positive changes in the lives of individuals and society.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240226721394/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom